(Q82366072)

English

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome

scientific article published on 01 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

Guillermo Garcia-Manero

7

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

11

object named as

Elihu Estey

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Hagop Kantarjian

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Susan O'brien

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jorge Cortes

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Francis Giles

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Stefan Faderl

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Elias Jabbour

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

William Wierda

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sherry Pierce

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jianqin Shan

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 March 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

106

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1090-1098

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: a review and updated results of the Australian Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission rate and survival in acute myeloid leukemia: impact of selection and chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute myelogenous leukemia in older adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of newly-diagnosed acute myelogenous leukaemia in patients aged 80 years and above

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of acute myeloid leukemia in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in elderly patients with acute myeloid leukaemia: development of a model to predict survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of risk group stratification in elderly patients with acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

The outcomes and costs of acute myeloid leukemia among the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21723

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21723

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16435386%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82366072&oldid=1948810308"